{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:06:57Z","timestamp":1784754417697,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P50CA70907"],"award-info":[{"award-number":["5P50CA70907"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20CA221731"],"award-info":[{"award-number":["P20CA221731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007914","name":"University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007144","name":"University of Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007144","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bioorg.2026.109578","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:44:34Z","timestamp":1769874274000},"page":"109578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multimerization approach to improve a cell surface plectin binding cancer stem cell targeted peptoid drug\u2011lead"],"prefix":"10.1016","volume":"172","author":[{"given":"Charles Owusu","family":"Ansah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gomika","family":"Udugamasooriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bioorg.2026.109578_bb0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109578_bb0010","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109578_bb0015","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.3390\/biomedicines10112988","article-title":"Cancer metastasis and treatment resistance: mechanistic insights and therapeutic targeting of cancer stem cells and the tumor microenvironment","volume":"10","author":"Kilmister","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109578_bb0020","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Dillek\u00e5s","year":"2019","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109578_bb0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/0008-5472.CAN-14-3225","article-title":"Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance","volume":"75","author":"Adorno-Cruz","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109578_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2015.12.001","article-title":"Cancer stem cells in drug resistant lung cancer: targeting cell surface markers and signaling pathways","volume":"158","author":"Leon","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109578_bb0035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109578_bb0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4252\/wjsc.v15.i6.576","article-title":"Clinical relevance of stem cells in lung cancer","volume":"15","author":"Romeo","year":"2023","journal-title":"World J. Stem. Cells"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109578_bb0045","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.21873\/anticanres.12663","article-title":"Lung Cancer stem cells and Cancer stem cell-targeting natural compounds","volume":"38","author":"Maiuthed","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2026.109578_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2017.00080","article-title":"\u2018Targeting lung Cancer stem cells: research and clinical impacts","volume":"7","author":"Zakaria","year":"2017","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109578_bb0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/stem.2787","article-title":"Concise review: resistance to tyrosine kinase inhibitors in non-small cell lung Cancer: the role of Cancer stem cells","volume":"36","author":"Del Re","year":"2018","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109578_bb0060","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4252\/wjsc.v7.i9.1185","article-title":"Therapies targeting cancer stem cells: current trends and future challenges","volume":"7","author":"DL","year":"2015","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.bioorg.2026.109578_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1125174","article-title":"Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics","volume":"11","author":"Borlongan","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109578_bb0070","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3892\/ijo.2017.4129","article-title":"Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (review)","volume":"51","author":"Katoh","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2026.109578_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bcp.2018.12.010","article-title":"Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting","volume":"160","author":"Sen Heng","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109578_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2008.07.012","article-title":"Cancer and stem cell biology: how tightly intertwined?","volume":"3","author":"Kim","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"7035","key":"10.1016\/j.bioorg.2026.109578_bb0085","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signalling in stem cells and cancer","volume":"434","author":"Reya","year":"2005","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109578_bb0090","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1021\/acschembio.5b00592","article-title":"Unbiased selection of peptide-peptoid hybrids specific for lung Cancer compared to Normal lung epithelial cells","volume":"10","author":"Matharage","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109578_bb0095","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.chembiol.2009.10.011","article-title":"Isolation of antagonists of antigen-specific autoimmune T cell proliferation","volume":"16","author":"Gocke","year":"2009","journal-title":"Chem. Biol."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109578_bb0100","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1021\/ja711193x","article-title":"A peptoid \u201cantibody surrogate\u201d that antagonizes VEGF receptor 2 activity","volume":"130","author":"Udugamasooriya","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109578_bb0105","first-page":"299","article-title":"Peptoids as potential therapeutics","volume":"11","author":"Zuckermann","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"20","key":"10.1016\/j.bioorg.2026.109578_bb0110","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.1073\/pnas.89.20.9367","article-title":"Peptoids: a modular approach to drug discovery","volume":"89","author":"Simon","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109578_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51004-3","article-title":"Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells","volume":"9","author":"Raymond","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109578_bb0120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.147.2.417","article-title":"Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding","volume":"147","author":"Geerts","year":"1999","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109578_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092453","article-title":"Identifying Plectin isoform functions through animal models","volume":"10","author":"Casta\u00f1\u00f3n","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109578_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/bioa.1.1.14630","article-title":"Plectin isoforms as organizers of intermediate filament cytoarchitecture","volume":"1","author":"Wiche","year":"2011","journal-title":"Bioarchitecture"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109578_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00401-012-1026-0","article-title":"The many faces of plectin and plectinopathies: pathology and mechanisms","volume":"125","author":"Winter","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bioorg.2026.109578_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ceb.2014.10.002","article-title":"Networking and anchoring through plectin: a key to IF functionality and mechanotransduction","volume":"32","author":"Wiche","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109578_bb0145","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.7150\/thno.23050","article-title":"Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer","volume":"8","author":"Dasa","year":"2018","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109578_bb0150","doi-asserted-by":"crossref","first-page":"0657","DOI":"10.1371\/journal.pmed.0050085","article-title":"Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma","volume":"5","author":"Kelly","year":"2008","journal-title":"PLoS Med."},{"issue":"48","key":"10.1016\/j.bioorg.2026.109578_bb0155","doi-asserted-by":"crossref","first-page":"19414","DOI":"10.1073\/pnas.1309720110","article-title":"Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer","volume":"110","author":"Shin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.bioorg.2026.109578_bb0160","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.yexcr.2011.07.013","article-title":"Plectin regulates invasiveness of SW480 colon carcinoma cells and is targeted to podosome-like adhesions in an isoform-specific manner","volume":"317","author":"McInroy","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109578_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/1570164614666171031154904","article-title":"Human disease-protein network","volume":"15","author":"Cheng","year":"2017","journal-title":"Curr. Proteomics"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109578_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092246","article-title":"Plectin in Cancer: from biomarker to therapeutic target","volume":"10","author":"Perez","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109578_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092218","article-title":"A novel monoclonal antibody targeting Cancer-specific Plectin has potent antitumor activity in ovarian Cancer","volume":"10","author":"Perez","year":"2021","journal-title":"Cells"},{"issue":"28","key":"10.1016\/j.bioorg.2026.109578_bb0180","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1002\/anie.201702242","article-title":"An organoruthenium anticancer agent shows unexpected target selectivity for Plectin","volume":"56","author":"Meier","year":"2017","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109578_bb0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0959-440X(00)00072-5","article-title":"Cell surface receptors","volume":"10","author":"C","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109578_bb0190","first-page":"244","article-title":"Designing multivalent ligands to control biological interactions: from vaccines and cellular effectors to targeted drug delivery","volume":"78","author":"Arsiwala","year":"2019","journal-title":"Aust. J. Public Adm."},{"key":"10.1016\/j.bioorg.2026.109578_bb0195","first-page":"199","article-title":"Multivalent inhibitors of channel-forming bacterial toxins","volume":"406","author":"Yamini","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109578_bb0200","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1367-5931(00)00153-8","article-title":"Synthetic multivalent ligands in the exploration of cell-surface interactions","volume":"4","author":"Kiessling","year":"2000","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109578_bb0205","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/anie.200502794","article-title":"Synthetic multivalent ligands as probes of signal transduction","volume":"45","author":"Kiessling","year":"2006","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"23","key":"10.1016\/j.bioorg.2026.109578_bb0210","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1021\/jm400794z","article-title":"Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1","volume":"56","author":"Jahromi","year":"2013","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109578_bb0215","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1021\/acs.jmedchem.0c00558","article-title":"Optimization of the linker domain in a dimeric compound that degrades an r(CUG) repeat expansion in cells","volume":"63","author":"Benhamou","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109578_bb0220","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/bip.21596","article-title":"Development of homomultimers and heteromultimers of lung cancer-specific peptoids","volume":"96","author":"Hooks","year":"2011","journal-title":"Biopolymers"},{"issue":"13","key":"10.1016\/j.bioorg.2026.109578_bb0225","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/cmdc.201600081","article-title":"A potent inhibitor of protein sequestration by expanded triplet (CUG) repeats that shows phenotypic improvements in a Drosophila model of myotonic dystrophy","volume":"11","author":"Luu","year":"2016","journal-title":"ChemMedChem"},{"issue":"26","key":"10.1016\/j.bioorg.2026.109578_bb0230","doi-asserted-by":"crossref","first-page":"8615","DOI":"10.1021\/ja061766n","article-title":"Optimization of bivalent glutathione S-transferase inhibitors by combinatorial linker design","volume":"128","author":"Mahajan","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109578_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105340","article-title":"A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells","volume":"116","author":"Shukla","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"36","key":"10.1016\/j.bioorg.2026.109578_bb0240","doi-asserted-by":"crossref","first-page":"18643","DOI":"10.1074\/jbc.M116.732909","article-title":"The structure of the plakin domain of plectin reveals an extended rod-like shape","volume":"291","author":"Ortega","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109578_bb0245","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cbdd.12042","article-title":"Peptide scanning for studying structure-activity relationships in drug discovery","volume":"81","author":"Jamieson","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109578_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1432","article-title":"A peptoid interleukin-15 receptor antagonist suppresses inflammation and arthritis in mice","volume":"11","author":"Cho","year":"2022","journal-title":"Clin. Transl. Immunol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109578_bb0255","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/bies.1151","article-title":"Plectin repeats and modules: strategic cysteines and their presumed impact on cytolinker functions","volume":"23","author":"Janda","year":"2001","journal-title":"Bioessays"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109578_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082154","article-title":"Plectin-mediated intermediate filament functions: why isoforms matter","volume":"10","author":"Wiche","year":"2021","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.bioorg.2026.109578_bb0265","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1016\/j.bmcl.2008.07.023","article-title":"The pharmacophore of a peptoid VEGF receptor 2 antagonist includes both side chain and main chain residues","volume":"18","author":"Udugamasooriya","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109578_bb0270","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of Normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109578_bb0275","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3892\/or_00000885","article-title":"Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance","volume":"24","author":"Honoki","year":"2010","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109578_bb0280","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3892\/mmr.2012.781","article-title":"Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma","volume":"5","author":"Zou","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109578_bb0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1432-0436.2006.00069.x","article-title":"A three-dimensional model of differentiation of immortalized human bronchial epithelial cells","volume":"74","author":"Vaughan","year":"2006","journal-title":"Differentiation"},{"issue":"17","key":"10.1016\/j.bioorg.2026.109578_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174148","article-title":"Robustness of Clonogenic assays as a biomarker for Cancer cell Radiosensitivity","volume":"20","author":"Matsui","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.bioorg.2026.109578_bb0295","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1016\/j.bmc.2017.07.062","article-title":"Biological evaluation of 2-pyrazolinyl-1-carbothioamide derivatives against HCT116 human colorectal cancer cell lines and elucidation on QSAR and molecular binding modes","volume":"25","author":"Kim","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109578_bb0300","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/0115701646253656231013141100","article-title":"LncRNA SH3BP5-AS1 regulates the proliferation and cell cycle of non-small cell lung Cancer cells","volume":"20","author":"Fan","year":"2023","journal-title":"Curr. Proteomics"},{"issue":"19","key":"10.1016\/j.bioorg.2026.109578_bb0305","first-page":"4597","article-title":"A current review on transdermal delivery of protein and peptides: possibilities and challenges","volume":"21","author":"Thakur","year":"2025","journal-title":"Lett. Drug. Des. Discov."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:59:50Z","timestamp":1784753990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826001148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":61,"alternative-id":["S0045206826001148"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109578","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimerization approach to improve a cell surface plectin binding cancer stem cell targeted peptoid drug\u2011lead","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109578"}}